Cost burden of stroke hits home in the UK

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.405, 2003-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirolimus-eluting stent superior: the REALITY hits home

Inpharma, Vol. 1, Iss. 1483, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

The Large and Growing Burden of Stroke

Current Drug Targets, Vol. 8, Iss. 7, 2007-07 ,pp. : 786-793

Bentham Science Publishers

Access to resources Recommend Favorite

Stroke Rehabilitation Services to Accelerate Hospital Discharge and Provide Home-Based Care: An Overview and Cost Analysis

By Anderson C.

PharmacoEconomics, Vol. 20, Iss. 8, 2002-08 ,pp. : 537-552

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Antiplatelet Therapy in the Prevention of Recurrent Stroke in the UK: Aspirin, Dipyridamole and Aspirin-Dipyridamole

By Chambers M.

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 577-593

Adis International

Access to resources Recommend Favorite

Tocilizumab cost effective in the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 607, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite